Reuters logo
3 个月前
BRIEF-Biosyent extends in-license agreement for cathejell
2017年4月20日 / 晚上8点03分 / 3 个月前

BRIEF-Biosyent extends in-license agreement for cathejell

1 分钟阅读

April 20 (Reuters) - Biosyent Inc:

* Biosyent extends in-license agreement for cathejell(r)

* Biosyent Inc - extended its license, distribution and supply agreement with its European partner, Pharmazeutische Fabrik Montavit GES.M.B.H.

* Extensio gives Biosyent Pharma exclusive Canadian rights to cathejell jelly 2 pct product until march 31, 2024 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below